Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial

BACKGROUND: A proposed cause of dyspnea induced by ticagrelor is an increase in adenosine blood levels. Because caffeine is an adenosine antagonist, it can potentially improve drug tolerability with regard to dyspnea. Furthermore, association between caffeine and cardiovascular events is of clinical...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Am Heart Assoc
Autores principales: Furtado, Remo H. M., Venkateswaran, Ramkumar V., Nicolau, Jose C., Gurmu, Yared, Bhatt, Deepak L., Storey, Robert F., Steg, P. Gabriel, Magnani, Giuglia, Goto, Shinya, Dellborg, Mikael, Kamensky, Gabriel, Isaza, Daniel, Aylward, Philip, Johanson, Per, Bonaca, Marc P.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7660882/
https://ncbi.nlm.nih.gov/pubmed/32410485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015785
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares